Biomatics Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
31
- Portfolio
-
8
- Exits
-
13
Biomatics Capital General Information
Company Description
Founded in 2016, Biomatics Capital is a venture capital investment firm based in Seattle, Washington. The firm seeks to invest in companies operating in the healthcare, technology and life science sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.biomaticscapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 188 East Blaine Street
- Suite 126
- Seattle, WA 98102
- United States
Biomatics Capital Investments (31)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Neumora | 11-Oct-2022 | Early Stage VC | Drug Discovery | Generating Revenue/Not Profitable | ||
| Encodia | 24-Jan-2021 | Biotechnology | Generating Revenue | |||
| Verve Therapeutics | 14-Jan-2021 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Thrive Earlier Detection | 24-Jul-2020 | Biotechnology | Generating Revenue | |||
| Compass Therapeutics | 19-Jun-2020 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Verve Therapeutics | 11-Jun-2020 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Guide Therapeutics | 13-Jan-2020 | Drug Delivery | Generating Revenue | |||
| Omniome | 10-Jan-2020 | Biotechnology | Generating Revenue | |||
| AiCure | 07-Nov-2019 | Later Stage VC | Outcome Management (Healthcare) | Generating Revenue | ||
| Egenesis | 01-Nov-2019 | Early Stage VC | Biotechnology | Pre-Clinical Trials |
Biomatics Capital Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Verve Therapeutics | 29-Nov-2023 | Public Investment 2nd Offering | |
| Neumora | 15-Sep-2023 | ||
| Compass Therapeutics | 04-Nov-2021 | ||
| Blackthorn Therapeutics | 07-Oct-2021 | ||
| Alairion | 01-Oct-2021 | ||
| Omniome | 20-Sep-2021 | ||
| GRAIL | 18-Aug-2021 | ||
| Verve Therapeutics | 17-Jun-2021 | ||
| Guide Therapeutics | 23-Feb-2021 | Merger/Acquisition | |
| Thrive Earlier Detection | 05-Jan-2021 | Merger/Acquisition |
Biomatics Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Biomatics Capital Co-Investors (31)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 2 |
|
|
||
| GV |
|
|
|||
| Altitude Life Science Ventures |
|
|
|||
| Citadel Enterprise Americas |
|
|
|||
| The Invus Group |
|
|
Biomatics Capital FAQs
-
What is Biomatics Capital?
Founded in 2016, Biomatics Capital is a venture capital investment firm based in Seattle, Washington.
-
When was Biomatics Capital founded?
Biomatics Capital was founded in 2016.
-
Where is Biomatics Capital headquartered?
Biomatics Capital is headquartered in Seattle, WA.
-
What is Biomatics Capital's total asset value?
Biomatics Capital has around in total assets under management.
-
How many investments has Biomatics Capital made?
Biomatics Capital has made 31 investments.
-
What has Biomatics Capital invested in?
Biomatics Capital has made numerous investments in companies like Neumora, Encodia, and Verve Therapeutics within the Drug Discovery and Biotechnology industries.
-
What has Biomatics Capital invested in recently?
Biomatics Capital's latest investment was on 11-Oct-2022 in Neumora, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
